Physician profile
Mark T Grusso
NPI 1144260175
$1,007.23
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $242 · 2021: $361 · 2022: $271 · 2023: $13.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $142.93 | 2019-2020 | |
| Alfasigma USA, INC. | $119.20 | 2021-2022 | |
| Kci USA, INC. | $93.91 | 2020-2022 | |
| Organogenesis INC. | $71.95 | 2021-2022 | |
| Treace Medical Concepts, INC. | $63.89 | 2022 | |
| Paragon 28, INC. | $63.61 | 2020-2022 | |
| Smith+Nephew, INC. | $51.31 | 2020-2022 | |
| Horizon Therapeutics Plc | $39.60 | 2022 | |
| Bioventus LLC | $39.55 | 2020-2021 | |
| Melinta Therapeutics, LLC | $38.31 | 2019 | |
| Misonix INC | $37.86 | 2021 | |
| Novus Surgical Consultants | $36.79 | 2022 | |
| Zimmer Biomet Holdings, INC. | $32.03 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.26 | 2019 | |
| Paratek Pharmaceuticals, INC. | $27.08 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $24.44 | 2021 | |
| Abbott Laboratories | $23.23 | 2021 | |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Depuy Synthes Sales INC. | $15.07 | 2019 | |
| Abbvie INC. | $14.44 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.72 | 2023 | Seglentis |
| Pfizer INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Grusso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.